Travoprost Ophthalmic Solution Solution/ Drops
Product Images NDC 68462-943

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic Solution (NDC 68462-943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1jpg (Carton1jpg)

Carton1jpg (Carton1jpg)
This is a product description for Travoprost Ophthalmic Solution, USP. It is a sterile solution for eye use only, containing travoprost 0.04 mg per mL. The solution also includes inactive ingredients such as polyoxyl 40 hydrogenated castor oil, boric acid, propylene glycol, sorbitol, zinc chloride, and pH adjusters. It is preserved in a bottle with an ionic buffered system. The recommended storage temperature is 2°C to 25°C. The usual dosage is one drop in the affected eye(s) once daily in the evening. It is distributed by Glenmark Pharmaceuticals Inc. in the USA and is a product of India.*
FDA Label Image

Logo1 (Cca929ee 3015 4008 Ace9 F89858aea1d7 00)

Logo1 (Cca929ee 3015 4008 Ace9 F89858aea1d7 00)
Glenmark is a pharmaceutical company that focuses on developing and manufacturing innovative medicines to improve the health and well-being of people globally. The company is dedicated to creating high-quality and affordable healthcare solutions for various medical needs.*
FDA Label Image

Image2jpg (Image 01)

Image2jpg (Image 01)
This is a description of Travoprost Ophthalmic Solution, USP, containing 0.04 mg of travoprost per mL. It is meant for eye use only and should be stored between 2°C to 25°C. The product is distributed by Glenmark Pharmaceuticals Inc. in the USA and is a product of India. Dosage instructions can be found in the insert included with the solution. The product has a National Drug Code (NDC) of 68462-043-05 and a unique Code No.: AP/DRUGS/103/97.*
FDA Label Image

Carton2jpg (Image 02)

Carton2jpg (Image 02)
This is a description of Travoprost Ophthalmic Solution, an eye medication used for conditions like glaucoma. Each mL of the solution contains 0.04 mg of travoprost, distributed by Glenmark Pharmaceuticals Inc., USA. The solution is an ionic buffered solution and is sterile. It is for eye use only and should be stored at a temperature between 2°C to 25°C. The usual dosage is one drop in the affected eye(s) once daily in the evening.*
FDA Label Image

Image1jpg (Image1jpg)

Image1jpg (Image1jpg)
NDC 68462-943-03 Each mL contains 0.04 mg of travoprost, for usual dosage, refer to the insert. The product is a non-ionic buffered solution distributed by Glenmark Pharmaceuticals Inc., USA. The manufacturer is Glenmark Pharmaceuticals and the product is from India. These details are mentioned on the packaging labeled AP/DRUGS/103/97.*
FDA Label Image

Travoprost-chemical-structure (Travoprost Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.